secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-05-27T20:39:45+00:00
Accession:  0001640334-26-000973
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences launches $6.53M ATM program; Craft Capital files FINRA claim for $880K
--------------------------------------------------------------------------------

- Entered at-the-market offering agreement with H.C. Wainwright to sell up to $6.53M of common stock, with 3.0% commission.
- Shelf registration (Form S-3) effective May 19, 2026; ATM prospectus supplement filed May 26, 2026.
- Craft Capital Management filed FINRA arbitration claim alleging breach of right of first refusal; seeks $880K success fee, warrants valued at $880K, plus late fees.
- Company terminated engagement with Craft on March 27, 2026 and closed private placement of ~$11M on March 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000973/0001640334-26-000973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000973/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer